• Mashup Score: 0
    The ASCO Post - 6 month(s) ago

    To view this email as a web page, click here. Could liquid biopsies help to determine which patients with oligometastatic NSCLC may be most likely to benefit from targeted, high-dose radiation therapy rather than drug-based therapy? A multi-institutional study investigated. Did prophylactic salpingo-oophorectomy improve survival in patients who underwent resection of germline BRCA1/2 -mutant breast cancer? A single-institution retrospective study explored the strategy. An analysis of patient-reported

    Tweet Tweets with this article
    • Surveyed Patients and Oncologists Share Thoughts on Complementary Cancer Therapies https://t.co/NL0SXBgTje #integrativeoncology #cancer #oncology

  • Mashup Score: 3

    The ASCO Post’s Integrative Oncology series is intended to facilitate the availability of evidence-based information on integrative and complementary therapies sometimes used by patients with cancer. In this installment, Yen Nien (Jason) Hou, PharmD, DiplOM, LAc, and Jyothirmai Gubili, MS, focus on the use of psilocybin—a naturally occurring psychedelic prodrug compound—given the growing interest in its use for mood disorders. Yen Nien (Jason) Hou, PharmD, DiplOM, LAc Common Names: Magic mushrooms,

    Tweet Tweets with this article
    • Use of Psilocybin for Mood Disorders in Patients With Cancer https://t.co/zg4Hw6qhC0 #psilocybin #integrativeoncology #cancer

  • Mashup Score: 3

    PURPOSE To provide evidence-based recommendations to health care providers on integrative approaches to managing anxiety and depression symptoms in adults living with cancer. METHODS The Society for Integrative Oncology and ASCO convened an expert panel of integrative oncology, medical oncology, radiation oncology, surgical oncology, palliative oncology, social sciences, mind-body medicine, nursing, methodology, and patient advocacy representatives. The literature search included systematic reviews, meta-analyses, and randomized controlled trials published from 1990 through 2023. Outcomes of interest included anxiety or depression symptoms as measured by validated psychometric tools, and adverse events. Expert panel members used this evidence and informal consensus with the Guidelines into Decision Support methodology to develop evidence-based guideline recommendations. RESULTS The literature search identified 110 relevant studies (30 systematic reviews and 80 randomized controlled tri

    Tweet Tweets with this article
    • 🚨 ICYMI @ASCO-@Integrativeonc #GuidelineUpdate published in #JCO: #IntegrativeOncology Care of #Anxiety and Depressive Symptoms in Adult Patients with Cancer 👉 https://t.co/FSkGhZsVux #psyonc #supponc https://t.co/OD3R2DrpU3

  • Mashup Score: 2

    Guest Editor’s Note: Psychological distress is highly prevalent in women diagnosed with premenopausal breast cancer and has a significant negative impact on their quality of life. Thus, effective strategies are urgently needed to reduce the symptom burden. In this installment of The ASCO Post’s Integrative Oncology series, Patricia A. Ganz, MD, FASCO, and Julienne E. Bower, PhD, both of UCLA,…

    Tweet Tweets with this article
    • Patricia A. Ganz, MD, FASCO, and Julienne E. Bower, PhD, on Targeting Depressive Symptoms in Younger Breast Cancer Survivors https://t.co/FgjpIXgZAR #bcsm #breastcancer #survivorship #depression #integrativeoncology @UCLA @UCLAJCCC

  • Mashup Score: 0

    AuthorsSarah P. PsutkaUniversity of Washington, Fred Hutchinson Cancer Center, Seattle, WASarah P. Psutka, Susan Veleber, Jonathan Siman, Sarah K. Holt, Samia Jannat, Jonathan L. Wright, Daniel W. Lin, John L. Gore, George Schade, Zachary Anton Annen, Heather GreenleeOrganizationsUniversity of Washington, Fred Hutchinson Cancer Center, Seattle, WA, Fred Hutchinson Cancer Center, Seattle, WA, Fred…

    Tweet Tweets with this article
    • On the plane to Chicago for #ASCO2023! Thrilled to present the results of our Phase I/II RCT of In-Clinic Acupuncture prior to intravesical BCG instillations on behalf of our amazing @fredhutch @uwurology #IntegrativeOncology team! https://t.co/3x4bq2bWU1

  • Mashup Score: 0
    Home - 1 year(s) ago

    SIO is the premier multi-disciplinary professional organization for integrative oncology. A 501(c)(3) not-for-profit organization, SIO enables communication, education, and research to occur by bringing together practitioners from multiple disciplines focused on the care of cancer patients and survivors.

    Tweet Tweets with this article
    • Learn more about the Society for #IntegrativeOncology #SIO @Integrativeonc and its mission — to advance evidence-based, comprehensive integrative #healthcare to improve the lives of people affected by #cancer. 🌐https://t.co/qPHkVQyetc